FN2 Earnings Intelligence
HCA Healthcare, Inc. financials
HCA Healthcare, Inc. (HCA) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,451 | $908 | $935 | $1,933 | $1,040 | - | - |
| + Debt | - | - | - | - | $46,492 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $58,752 | $60,233 | $64,968 | $70,603 | $75,600 | $78,462.9 | $81,774.5 |
| % Growth | 14.0% | 2.5% | 7.9% | 8.7% | 7.1% | 3.8% | 4.2% |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $6,956 | $5,643 | $5,242 | $5,760 | $6,784 | - | - |
| % Margin | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% | - | - |
| Diluted EPS | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 | $29.84 | $32.75 |
| % Growth | 93.6% | -9.5% | -0.9% | 16.0% | 28.8% | 5.3% | 9.8% |
| Operating Cash Flow | $8,959 | $8,522 | $9,431 | $10,514 | $12,636 | - | - |
| CapEx | $3,577 | $4,395 | $4,744 | $4,875 | $4,944 | - | - |
| Free Cash Flow | $5,382 | $4,127 | $4,687 | $5,639 | $7,692 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $58,752 | $60,233 | $64,968 | $70,603 | $75,600 | $78,462.9 | $81,774.5 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $6,956 | $5,643 | $5,242 | $5,760 | $6,784 | - | - |
| Diluted EPS | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 | $29.84 | $32.75 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,451 | $908 | $935 | $1,933 | $1,040 |
| Short-term Debt | - | - | - | - | $4,889 |
| Long-term Debt | $34,342 | $37,714 | $37,169 | $38,333 | $41,603 |
| Total Debt | - | - | - | - | $46,492 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $8,959 | $8,522 | $9,431 | $10,514 | $12,636 |
| Capital Expenditure | $3,577 | $4,395 | $4,744 | $4,875 | $4,944 |
| Free Cash Flow | $5,382 | $4,127 | $4,687 | $5,639 | $7,692 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 14.0% | 2.5% | 7.9% | 8.7% | 7.1% |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
| FCF Margin | 9.2% | 6.9% | 7.2% | 8.0% | 10.2% |
| Diluted EPS Growth | 93.6% | -9.5% | -0.9% | 16.0% | 28.8% |